Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00264732 · ClinicalTrials.gov registry record · Phase 2
A Study of Amolimogene (ZYC101a) in Patients With High Grade Cervical Intraepithelial Lesions of the Uterine Cervix
A Phase 2 study of Uterine Cervical Dysplasia, sponsored by Eisai.
- Completed
- Registry status
- Phase 2
- Development phase
- 251
- Enrollment target
- 20
- Study locations
NCT00264732: Completed Phase 2 study of Uterine Cervical Dysplasia, sponsored by Eisai.
NCT00264732 is a Phase 2 study of Uterine Cervical Dysplasia that has completed, run by Eisai. The registered enrollment target is 251 participants, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (89% higher). The trial reports 20 study locations across 13 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00264732, a Phase 2 study of Uterine Cervical Dysplasia, has completed, sponsored by Eisai.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 251 participants
- Enrollment target
- 20
- Study locations
Study Summary
The purpose of this study is to evaluate the efficacy and safety of amolimogene, in the treatment of patients with high-grade cervical intraepithelial lesions of the uterine cervix.
Conditions Studied
Interventions
- OTHER Placebo
- DRUG Amolimogene
Study Locations (20)
Florida
- Visions Clinical Research - Boynton Beach
- University of Florida, Miami - Miami
- Physician Care Clinical Research - Sarasota
- Insignia Clinical Research - Tampa
- Comprehensive Clinical Trials LLC - West Palm Beach
California
- Arrowhead Regional Medical Center - Colton
- The Center for Advanced Research and Education, Inc. - Palm Springs
- Medical Center for Clinical Research - San Diego
Arizona
- Arizona Wellness Center for Women/Precision Trials, LLC - Phoenix
- University of Arizona - Tucson
Alabama
- University of Alabama - Birmingham
Colorado
- Physicians Research Options, LC - Lakewood
Georgia
- Medical College of Georgia, Department of Family Medicine - Augusta
Idaho
- Rosemark Women's Care Specialists - Idaho Falls
Minnesota
- University of Minnesota - Minneapolis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 251 participants |
| Start Date | 2005-07 |
| Est. Completion | 2009-05 |
| Phase | Phase 2 |
What the finished NCT00264732 record still lists
NCT00264732 is an interventional study that assigns participants to a tested intervention. The registered 251 participants enrollment target is mid-sized for trials with a published cap, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (89% higher).
The record links to 1 condition, with Uterine Cervical Dysplasia appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT00264732 names 20 study sites across 13 states, led by Florida, California, Arizona.
Frequently Asked Questions
What is clinical trial NCT00264732 about?
NCT00264732 is a clinical study titled "A Study of Amolimogene (ZYC101a) in Patients With High Grade Cervical Intraepithelial Lesions of the Uterine Cervix". The purpose of this study is to evaluate the efficacy and safety of amolimogene, in the treatment of patients with high-grade cervical intraepithelial lesions of the uterine cervix.
What is the current status of trial NCT00264732?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 251 participants. The study started on 2005-07. Estimated completion is 2009-05.
What conditions does trial NCT00264732 study?
This clinical trial studies the following conditions: Uterine Cervical Dysplasia.
What interventions are being tested in trial NCT00264732?
The interventions under investigation include: Placebo (OTHER), Amolimogene (DRUG).
Who is sponsoring clinical trial NCT00264732?
This trial is sponsored by Eisai, which has 287 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00264732 being conducted?
This trial has 20 study locations across Alabama, Arizona, California, Colorado, Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Uterine Cervical Dysplasia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00264732's enrollment target sits among peer trials
251 222nd of 2000 higher than 1,779 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06043817 · 251 participants · Phase 1
First-In-Human Study of STX-721/PFL-721 in Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer Harboring EGFR or HER2 Exon 20 Insertion Mutations
- NCT02314988 · 252 participants · Phase 2
Tranexamic Acid to Reduce Blood Loss in Spine Surgery
- NCT03941756 · 252 participants · NA
Lymphovenous Bypass Procedure Before Underarm Lymph Node Surgery in Preventing Lymphedema in Patients With Inflammatory or Locally Advanced Non-inflammatory Breast Cancer or Melanoma
- NCT05219617 · 252 participants · Phase 3
Investigate Efficacy and Safety of Carisbamate as Adjunctive Treatment for Seizures Associated With LGS in Children and Adults
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia